We have tested a hypothesis that the natural product curcuminoids, which has epidemiologic and experimental rationale for use in AD, may improve the innate immune system and increase amyloid-␤ (A␤) clearance from the brain of patients with sporadic Alzheimer's disease (AD). Macrophages of a majority of AD patients do not transport A␤ into endosomes and lysosomes, and AD monocytes do not efficiently clear A␤ from the sections of AD brain, although they phagocytize bacteria. In contrast, macrophages of normal subjects transport A␤ to endosomes and lysosomes, and monocytes of these subjects clear A␤ in AD brain sections. Upon A␤ stimulation, mononuclear cells of normal subjects up-regulate the transcription of ␤-1,4-mannosyl-glycoprotein 4-␤-N-acetylglucosaminyltransferase (MGAT3) (P < 0.001) and other genes, including Toll like receptors (TLRs), whereas mononuclear cells of AD patients generally down-regulate these genes. Defective phagocytosis of A␤ may be related to down-regulation of MGAT3, as suggested by inhibition of phagocytosis by using MGAT3 siRNA and correlation analysis. Transcription of TLR3, bditTLR4, TLR5, bditTLR7, TLR8, TLR9, and TLR10 upon A␤ stimulation is severely depressed in mononuclear cells of AD patients in comparison to those of control subjects. In mononuclear cells of some AD patients, the curcuminoid compound bisdemethoxycurcumin may enhance defective phagocytosis of A␤, the transcription of MGAT3 and TLRs, and the translation of TLR2-4. Thus, bisdemethoxycurcumin may correct immune defects of AD patients and provide a previously uncharacterized approach to AD immunotherapy.
ccording to the amyloid-␤ (A␤) hypothesis, amyloidosis occurring in the brain of patients with Alzheimer's disease (AD) by fibrillar A␤ 1-42 and 1-40 (1) and A␤ oligomers (2) is a leading cause of neurodegeneration in AD (3) . Macrophages and microglia are the innate immune cells responsible for clearance of pathogens and waste products. We have shown that blood-borne monocyte/ macrophages of AD patients migrate across the blood-brain barrier into AD brain but are defective in clearance of A␤ in neuritic plaques (4) , and they overexpress cyclooxygenase-2 and inducible NO synthase (4) . Resident microglia in AD brain display markers of inflammation (5, 6) , phagocytosis (7) , and proinflammatory but not prophagocytic genes (8) . However, most microglia invading A␤ plaques in transgenic mouse models are bone marrow-derived, not resident microglia (9) . Thus, the brains of AD patients and transgenic mice seem to display inflammatory responses by microglia and defective A␤ clearance by blood-borne macrophages. Consequently, the defective innate immune system of AD patients might be a culprit in brain amyloidosis leading to brain inflammation.
The mechanisms of neurodegeneration produced by abnormally folded proteins, A␤, and phosphorylated remain an enigma (10) .
The pathogenesis of neurodegeneration in AD involves the impact of polymorphic proteins, such as amyloid precursor protein (APP), apolipoprotein E (11, 12) , sortilin-related receptor, low-density lipoprotein receptor class A repeat-containing protein (SORL1) (13) , reelin (14) , interleukin 1, ␣1-antichymotrypsin, and ␣2-macroglobulin (15, 16) on cellular processes, such as APP processing (13) , oxidative stress (17, 18) , and neuronal apoptosis (19) (20) (21) . However, A␤ accumulation is considered the major mechanism susceptible to therapy (22) .
To clarify the role of the innate immune system in brain amyloidosis, we investigated A␤ phagocytosis and transcriptional regulation by macrophages and peripheral blood mononuclear cells (PBMCs) of AD patients and controls. In addition, we tested immune modulation of A␤ phagocytosis and gene transcription and translation by treatment with the compound bisdemethoxycurcumin derived from curcuminoids.
Results
Transcriptional Down-Regulation of MGAT3 and Other Genes in PBMCs of AD Patients. In the initial study using the Operon platform, we performed microarray analysis of mRNAs isolated from PBMCs of two patients and two controls. Compared with AD cells, after overnight treatment with A␤, control cells up-regulated (Ͼ2.2-fold) the transcription of 35 genes and expressed sequence tags, including MGAT3 (327-fold, P Ͻ 0.001), fibronectin (FN1) (10.1-fold, P Ͻ 0.001), cholinergic receptor, muscarinic 4 (9.3-fold, P Ͻ 0.001), and 2Ј-5Ј-oligoadenylate synthetase 3 (7.8-fold, P Ͻ 0.001), and downregulated (Ͼ2-fold) the transcription of 35 genes or ESTs (Table 1) .
To confirm these transcriptional differences, we investigated, using quantitative PCR (qPCR), the MGAT3 responses to A␤ in PBMCs of 18 patients and nine control subjects (Fig. 1) . Twelve patients down-regulated MGAT3 ratio (0.00001-0.99) and six patients (three Ͼ80 years old) up-regulated the expression of MGAT3 ratio. The controls up-regulated the MGAT3 ratio upon A␤ stimulation with the exception of two subjects Ͼ80 years old. The control and AD groups had equal MGAT3 variances by Levene's test and comparable age distribution; therefore, ANOVA testing was appropriate. The mean log 10 MGAT3 RNA score (Ϫ1.2670) of AD patients was significantly lower in comparison to the mean score of control subjects (ϩ2.190) (P ϭ 0.025 by ANOVA). In the 60-to 80-year population sample, the mean log MGAT3 RNA scores of AD patients (Ϫ1.747) and control subjects (ϩ3.77) showed an even greater difference (P ϭ 0.001 by ANOVA). Repeat assays of the same patient showed an MGAT3 ratio of 0.04 in the first sample and MGAT3 ratios of 0.31 and 0.35 (duplicates) in the second sample 3 months later. In addition, we confirmed by qPCR testing of AD PBMCs transcriptional down-regulation of two other genes noted in the microarray analysis, FN1 and 2Ј-5Ј-oligoadenylate synthetase 3.
Relation of A␤ Phagocytosis to Transcription and Translation of

MGAT3.
A review of the results of FITC-A␤ phagocytosis by macrophages of 42 control subjects and 73 patients examined in our prospective studies (2001) (2002) (2003) (2004) (2005) (2006) (2007) showed that macrophages of control subjects usually (Ϸ80%) showed excellent ( Fig. 2A) or, rarely (Ϸ10%), extremely efficient (Fig. 2B ) phagocytosis of soluble FITC-A␤ in 24 h. In contrast, macrophages of AD patients displayed either minimal surface uptake of FITC-A␤ (60% of patients) (Fig. 2C) , no intracellular but strong surface uptake (25%) (Fig. 2D ), or extremely efficient phagocytosis (as in Fig. 2B ) (15%). The relationship between MGAT3 ratio and FITC-A␤ uptake integrated optical density (IOD) per macrophage was analyzed in eight AD patients and four control subjects. The correlation coefficient of MGAT3 RNA score with IOD was 0.454 (P Ͻ 0.069) [supporting information (SI) Fig. 7 ].
To determine directly the effect of MGAT3 on phagocytosis of FITC-A␤, we transfected control PBMCs using MGAT3 siRNA or a control vector or did not transfect them. MGAT3 siRNA trans- Microarray analysis was performed with RNA isolated from 10 million PBMCs of two patients and two control subjects incubated overnight with A␤ (2 g/ml). The results indicate RNA in control PBMCs compared with AD. NA, not applicable. The downstream effect of MGAT3 on phagocytosis may depend upon Toll-like receptors (TLRs), which play a crucial role in the detection of nonself by the innate immune system (23) . Therefore, we tested transcription and translation of TLRs in PBMCs.
Transcription of TLRs in Mononuclear Cells of AD Patients and Control
Subjects. Using PBMCs of four patients and three control subjects, we examined the transcription of TLRs by PBMCs of patients and controls. Upon A␤ stimulation, AD PBMCs generally downregulated TLR ratios, whereas control PBMCs up-regulated TLR ratios. TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, and TLR10 ratios exhibited the greatest difference between patients and control subjects (Fig. 4) . Repeat testing of TLR ratios showed comparable results: up-regulation in a control subject and down-regulation in an AD patient.
Previously, we reported that a natural product curcuminoids enhanced phagocytosis of A␤ by macrophages from AD patients in Ϸ50% of the cases examined (24) . We sought to identify the curcuminoid compound that is most transcriptionally and translationally active.
Bisdemethoxycurcumin Is the Most Potent Curcuminoid Compound, Which Enhances A␤ Phagocytosis, MGAT3, and TLR Transcription and
Translation. By an iterative process that was biodirected according to the FITC-A␤ uptake to identify active fractions from curcuminoids, we isolated the most potent immunostimulatory component. The material was purified to near homogeneity and identified by liquid chromatography-MS as bisdesmethoxycurcumin on the basis of its molecular ion and fragmentation pattern. To verify the biological activity of this minor constituent, bisdesmethoxycurcumin was chemically synthesized and tested in the phagocytosis and transcription assays described above. Both the bisdesmethoxycurcumin material isolated by chromatography and the chemically synthesized bisdesmethoxycurcumin material optimally stimulated phagocytosis at 0.1 M (SI Fig. 8 ).
To determine whether functional improvement would be accompanied by transcriptional changes, we tested transcriptional upregulation of MGAT3 and TLRs in PBMCs from AD patients and controls in the presence of A␤ with bisdesmethoxycurcumin (0.1 M) in comparison to A␤ alone. Bisdemethoxycurcumin improved the transcription of MGAT3 in all four patients (SI Fig. 9 ). We tested bisdemethoxycurcumin effect on TLR transcription in PBMCs of one patient. TLR ratios of all 10 TLRs were up-regulated by bisdemethoxycurcumin in this patient (see striped bars in Fig. 4 , D vs. DЈ). To demonstrate the effect of bisdemethoxycurcumin on TLR protein expression, we performed flow cytometry of PBMCs treated with this compound. A␤ and bisdemethoxycurcumin increased the expression of TLR2 (see SI Fig. 10 ), TLR3, and TLR4 on monocytes.
To determine the intracellular blocks to A␤ phagocytosis, we performed confocal microscopy of macrophages.
Endocytosis and Intracellular Transport of A␤ in Macrophages.
In control subjects' macrophages, the intracellular transport of 〈␤ was rapid, but in most AD patients' macrophages, transport of 〈␤ progressed slowly or not at all. One and 2 h after exposure of control subjects' macrophages, FITC-A␤ colocalized with the early endosomal marker Rab 5. In contrast, Rab5 staining and colocalization were minimal in AD patients' macrophages (Figs. 5 A vs. F) . The colocalization with the transferrin receptor EEA1 was apparent in control subjects' macrophages but not in AD patients' macrophages ( Fig. 5 B vs. G) . In control subjects' macrophages, FITC-A␤ colocalized with the lysosomal marker Lysotracker at each time interval 1, 48, and 72 h after exposure (Fig. 5 C-E) . In contrast, in AD patients' macrophages, the A␤ cargo bound to the cell surface but did not progress to lysosomes over a 72-h period, and the lysosomes were poorly expressed ( Fig. 5 H 
-J).
Macrophages from both control subjects and patients showed efficient phagocytosis of fluorescently labeled Escherichia coli and Staphylococcus aureus (SI Fig. 11 ). Scrambled FITC-A␤ was not taken up by AD or control macrophages.
Uploading of A␤ in Alzheimer's Brain Sections by Control and AD
Monocytes. To test the phagocytic ability of monocytes for 〈␤ species in the brain, we cocultured PBMCs with frozen sections of Alzheimer's brain. In serial experiments, we cocultured PBMCs of four AD patients and four controls with frozen sections of the frontal lobes of three AD patients. The results were consistent, and representative results are shown in the Fig. 6 . One-third (12 of 37) of control subjects' monocytes (green) became saturated with A␤ (yellow) in 2 days (Fig. 6A ) and 100% (35) in 4 days (Fig. 6B) . In contrast, less than one-quarter (7 of 30) of AD patients' monocytes became saturated with A␤ in 2 days (Fig. 6E) ; in 4 days, the remaining AD patients' monocytes were shrunken and aggregated into approximately nine clusters that stained red and yellow, suggestive of monocyte aggregation and A␤ release (Fig. 6F) . In brain sections double-stained with anti-CD68 (green)/anti-NeuN (red), monocytes adhered to neurons; whereas control monocytes impinged on neurons (appearing round and yellow) (Fig. 6 C and  D) , AD monocytes shriveled (appearing small and green) (Fig. 6 G  and H) . The brain section cultures were performed in Iscove's medium with 10% FCS, which excluded the role of antibodies in brain clearance of A␤.
Discussion
Upon A␤ stimulation, mononuclear cells of AD patients showed defective phagocytosis and transcriptional down-regulation in comparison to control mononuclear cells. The deficiency of innate immunity was highlighted by defective phagocytosis of A␤ in vitro as well as poor clearance of AD brain sections by AD monocytes. The most prominent transcriptional defect of AD PBMCs involved down-regulation of MGAT3 transcription upon A␤ stimulation. MGAT3 may be a key molecule in phagocytosis of 〈␤, because silencing its transcription inhibited A␤ phagocytic function of control monocytes. The product of the MGAT3 gene is Nacetylglucosaminyltransferase III (GlcNAc-TIII) (25, 26) , which transfers the bisecting N-acetylglucosamine to the core mannose of complex N-glycans (25, 27) . GlcNAc-TIII stops further processing and elongation of N-glycans (28) . GlcNAc-TIII modulates cell interactions, such as decreased binding of the erythroagglutinin from Phaseolus vulgaris to Chinese hamster ovary cells (29) . Animals with truncated inactive GlcNAc-TIII show neurological dysfunction (30) . GlcNAc-TIII potentiates ␤1 integrin-mediated neuritogenesis (31) . ␣2␤1 and ␣V␤1 integrins may recognize and be activated by amyloidogenic proteins (32) and thus could be the targets of GnT-III. The overexpression of GlcNAc-TIII protects against hydrogen peroxide-induced apoptosis (33) . We speculate that, because AD macrophages are more susceptible to apoptosis by A␤ in comparison to control macrophages (26), they might be stabilized by MGAT3 overexpression. Furthermore, altered glycosylation noted in AD (14) could be related to transcriptional dysregulation of GlcNAc-TIII.
Abnormal processing of APP assumes an important role in AD, as suggested by misdirection of APP into A␤-generating compartments when SORL1 is underexpressed (13) . Neurons of patients with Down's syndrome (34) display abnormal lysosomes (35) and defective hydrolases. Abnormalities of lysosomal degradation are also noted in patients with presenilin 1 mutation and sporadic AD patients (36) .
TLRs are crucial for macrophage function. We found a striking difference in TLR mRNA levels between control and AD PBMCs stimulated with A␤, where AD cells expressed lower levels of all TLRs tested. TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, and TLR10 exhibited the greatest difference. TLRs are pattern recognition receptors found on many cells types, including cells of the innate immune system, and they recognize conserved pathogen associated molecular patterns. Activation of a TLR results in many functional outcomes, including the enhancement of apoptosis, secretion of inflammatory cytokines, and direct antimicrobial activity (37) . The lower expression levels of TLRs on AD macrophages may be indicative of more global innate immune defects beyond A␤ phagocytosis. The innate and adaptive immune systems of AD patients appear to be in various states of disharmony. We previously observed that the intracellular levels of both T H1 -(IL-12 and IFN-␥) and T H2 -(IL-10) cytokines in mononuclear cells are significantly higher in AD patients in comparison to control subjects (26) . Discrepant serum and cerebrospinal fluid levels of cytokines in different studies [either increased or significantly diminished levels (38) ] also suggest that the coordination between adaptive and innate immune systems may change with the stage of the disease.
The immunotherapeutic A␤ vaccine strategy was designed in animal models to increase A␤ clearance by microglia through Fc␥ receptor phagocytosis (39) . However, the clearance of human AD brain may depend on bone marrow-derived macrophages (4) rather than resident brain microglia. Furthermore, antibody opsonization could increase inflammation (40) . Therefore, the enhancement of A␤ phagocytosis (24) and gene transcription in macrophages using the natural substance curcuminoids may have important applications to the immunotherapy of AD. However, it is not clear whether the blood levels achieved after oral administration of curcuminoids would be therapeutic. Here we have isolated bisdemethoxycurcumin as the most immunoenhancing chemical in curcuminoids, which also increased Mgat3 and TLR transcription. Our results show that bisdemethoxycurcumin is active at 0.1 M in vitro, and such blood level could be achieved by infusion. Therefore, our results may provide an entirely different direction to therapeutic opportunities in AD through the repair of the functional and transcriptional deficits of AD macrophages by curcuminoids. PBMCs and Macrophage Cultures. PBMCs were isolated by the Ficoll-Hypaque gradient technique from venous blood (20-30 ml) and were differentiated into adherent macrophages (7-14 days) as described (42) . See SI Text for details.
Materials and Methods
Phagocytosis Assay, Fluorescence, and Confocal Microscopy. Testing of FITC-A␤ (1-42) phagocytosis was performed as described (42) . See SI Text for details. Microarray Hybridization. Hybridization to the Operon Human Genome Oligo Set Version 3.0 (Operon, Huntsville, AL) was performed at the Duke Microarray Facility. ANOVA was performed by using the software VizX GeneSifter. Genes with P Ͻ 0.05 and a fold change of at least 3-fold were selected for further testing by qPCR. See SI Text for details.
qPCR. The expression levels of the genes of interest were tested by qPCR on an Opticon real-time PCR detector (BioRad, Hercules, CA) as described (44) . The relative quantities of the genes tested were calculated against h36B4 as a reference using the ⌬⌬CT (CT, cycle threshold) formula, as described (44 The most active fraction corresponded to bisdemethoxycurcumin, which was also chemically synthesized and successfully tested (SI Fig. 7 ). See SI Text for additional information.
